-
Mashup Score: 16MSK Research Highlights, November 21, 2024 - 3 day(s) ago
New MSK research investigates how pancreatic cancer cells regulate their genome to avoid immune attack; shows promise against glioblastoma in mouse models; and develops a new method to study cancer evolution.
Source: www.mskcc.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 29
Based on a clinical trial led by an MSK investigator, the FDA has approved revumenib (Revuforj®) for patients one year and older who have leukemia that has come back after treatment and whose cancer carries a molecular change called a KMT2A translocation.
Source: www.mskcc.orgCategories: General Medicine News, Oncologists1Tweet-
🚨NEW: The FDA has approved #revumenib for kids & adults with #leukemia that's come back after treatment & whose cancer carries a KMT2A translocation. MSK's Dr. Eytan Stein led the trial that brought about the drug's approval. Learn more: https://t.co/a3mAwxGbhi https://t.co/MYYeq2mFgY
-
-
Mashup Score: 20Beyond the Bench: Joan Massagué - 5 day(s) ago
Along with their alluring beauty, minerals — like scientific ideas — open a window onto the history of the world, Dr. Massagué says.
Source: www.mskcc.orgCategories: General Medicine News, Oncologists1Tweet-
Dr. Joan Massagué, Director of the Sloan Kettering Institute & Chief Scientific Officer for MSK, is known for his research in #cancerbiology. Another place where he's in his element: among fellow rockhounds enchanted by the beauty of crystals. More: https://t.co/yEmPuROfwh https://t.co/ioguszXGD5
-
-
Mashup Score: 5
Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.
Source: www.mskcc.orgCategories: General Medicine News, Oncologists1Tweet-
MSK thoracic oncologist Dr. Helena Hu shares why #lungcancer is more common in women than men in the 35-to-54 age group and why people can get lung cancer even if they’ve never smoked. Learn more ⬇️ https://t.co/jDezGXAS5Z https://t.co/sRpF98leFR
-
-
Mashup Score: 3Research Fellowship in Psycho-Oncology (NCI T32) - 7 day(s) ago
Funded by the National Cancer Institute more than three decades ago, this research training program provides extensive opportunities to develop research expertise in psycho-oncology and cancer prevention and control. Graduates of this program are leading researchers in cancer centers, academic medical centers and universities nationwide.
Source: www.mskcc.orgCategories: General Medicine News, Hem/OncsTweet-
RT @FIPOLatino: Apply Now to Our Research Fellowship Program! https://t.co/rzcow5ccW6 Our 2-3 year program offers mentorship, training, and…
-
-
Mashup Score: 4
Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.
Source: www.mskcc.orgCategories: General Medicine News, Oncologists1Tweet-
MSK thoracic oncologist Dr. Helena Hu shares why #lungcancer is more common in women than men in the 35-to-54 age group and why people can get lung cancer even if they’ve never smoked. Learn more ⬇️ https://t.co/jDezGXAS5Z https://t.co/sRpF98leFR
-
-
Mashup Score: 11Pharmacy PGY-2 Residencies - 10 day(s) ago
The Pharmacy Department offers three PGY-2 residency programs — focusing on pediatric oncology, adult oncology, and quality and patient safety, respectively — allowing the resident to specialize in his or her area of interest.
Source: www.mskcc.orgCategories: General Medicine News, Onc News and JournalsTweet-
First-year #pharmacy residents are invited to apply for MSK's second-year residency program by January 2, 2024. MSK is hosting multiple information sessions before then, including one this Wednesday 10/25. Visit https://t.co/yQHhWenDMn to learn more.
-
-
Mashup Score: 12MSK Research Highlights, November 6, 2024 - 12 day(s) ago
New MSK research marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; uncovers how changes to “helper” proteins drive cancer cell survival; develops a new model for investigating lung cancer metastasis; and uses AI to improve outcome predictions in sarcoma.
Source: www.mskcc.orgCategories: General Medicine News, Oncologists1Tweet-
New research from MSK marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; and more ⬇️ https://t.co/MNfwo9JCLy https://t.co/vUFmPSFpQo
-
-
Mashup Score: 106
Mitochondria provide both the energy cells need to survive and the building blocks they need to grow and divide. Researchers at the Sloan Kettering Institute reveal for the first time how mitochondria choose between these opposing paths — and what implications it may have for cancer.
Source: www.mskcc.orgCategories: General Medicine News, Oncologists1Tweet-
Dr. Craig Thompson and his colleagues in the Cancer Biology and Genetics Program at MSK's Sloan Kettering Institute recently published a paper in @Nature that shows how #mitochondria form two distinct subpopulations under #stress. Learn more: ➡️ https://t.co/lJ6cRQ036L https://t.co/FRDorE7wNv
-
-
Mashup Score: 19MSK Awards and Appointments October 2024 - 24 day(s) ago
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
Source: www.mskcc.orgCategories: General Medicine News, Oncologists1Tweet-
Congratulations to MSK's most recent Awards & Appointments honorees, including Dr. Deb Schrag and @studerl being elected to the @theNAMedicine, @NGoelMD for being selected for the Biden Cancer Moonshot Scholars Program, and more: https://t.co/USsMitLGVy https://t.co/lDmKK3JoVx
-
New research from MSK investigates how #pancreaticcancer cells regulate their genome to avoid immune attack; shows promise against #glioblastoma in mouse models; and develops a new method to study cancer evolution. Learn more ⬇️ https://t.co/oXHM02YBFd https://t.co/ebbI7lqakP